Precision Colchicine Intervention to Suppress Atherosclerosis in TET2 Clonal Hematopoiesis
Conditions
Colchicine · Coronary Atherosclerosis Management · Clonal Hematopoiesis of Indeterminate Potential
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
General Hospital of Northern Theater Command, Shenyang, Liaoning, China
Contact: Principal Investigator (Yaling Han, MD, PhD)
Study leads
Yaling Han, MD, PhD
Study Chair
The General Hospital of Northern Theater Command